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background: Revascularization of calcified coronary lesions has been shown to be associated with suboptimal outcomes. The optimal 
revascularization strategy for calcified lesions in patients presenting with non-ST-segment elevation acute coronary syndromes (NSTEACS) has yet to 
be defined.
Methods: Outcomes in patients presenting with NSTEACS and moderately or severely calcified target lesions in native coronary vessels, as assessed 
by an independent angiographic core lab, were examined according to revascularization strategy (PCI vs. CABG) from the large-scale, prospective 
ACUITY trial. Propensity-adjusted multivariable analysis was used to identify the independent predictors of events at 30 days.
results: Of 1,315 NSTEACS patients with moderately and severely calcified lesions in whom revascularization was performed, 334 (25%) and 981 
(75%) underwent CABG and PCI, respectively. CABG patients had more severe baseline co-morbidities and coronary artery disease. By propensity-
adjusted multivariable analysis, the CABG group had higher 30-day rates of reinfarction, composite death or reinfarction, major bleeding, and 
thrombocytopenia (Table).
conclusions: In this large-scale study of patients presenting for NSTEACS, 30-day adverse events were more frequent after revascularization of 
calcified coronary lesions with CABG rather than PCI. Further studies are warranted to evaluate means of improving early safety outcomes in this 
high-risk patient group with complex coronary disease.
Table. Thirty-Day Outcomes for PCI vs. CABG in Moderately to Severely Calcified Target Lesions
CABG
(N=334)
PCI
(N=981)
Adjusted Hazard Ratio
Adjusted
p-value
All-cause death 7 (2.1) 12 (1.2) 1.17 [0.30, 4.63] 0.82
Reinfarction 55 (16.5) 89 (9.1) 1.72 [1.09, 2.69] 0.02
Reinfarction or death 59 (17.7) 95 (9.7) 1.70 [1.09, 2.64] 0.02
Total major bleeding 181 (54.2) 91 (9.3) 5.88 [4.12, 7.69] <0.0001
Thrombocytopenia* 199 (59.6) 89 (9.1) 7.24 [5.35, 9.82] <0.0001
MACE 60 (18.0) 124 (12.7) 1.27 [0.83, 1.93] 0.27
Values presented as n (%); Thrombocytopenia defined as platelet count <150,000/mm3; MACE=Major Adverse Cardiovascular Events (death, 
myocardial infarction unplanned revascularization for ischemia, stroke).
